Skip to main content
Clinical Trials/IRCT20170619034621N2
IRCT20170619034621N2
Recruiting
Phase 2

Effect of prophylactic intracoronary adenosine injection during percutaneous coronary intervention on Thrombolysis In Myocardial Infarction frame count in patients with non ST-elevation myocardial infarction

Rajaiee Heart Center0 sites50 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
on ST elevation myocardial infarction.
Sponsor
Rajaiee Heart Center
Enrollment
50
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rajaiee Heart Center

Eligibility Criteria

Inclusion Criteria

  • chest pain or equivalent angina refer to myocardial ischemia
  • past less than 72 hours from onset of symptoms
  • ECG with ST depression or T wave inversion or normal ECG
  • elevated troponin
  • the patients candidate for PCI and their coronary stenosis suitable for stenting
  • age more than 18 years
  • fill out an informed constant form

Exclusion Criteria

  • History of asthma and chronic obstructive pulmonary disease
  • Treatment with dipyridamole
  • life expectancy less than 6 months
  • Cardiogenic shock (sustain SBP\<90 mmHg)
  • Post coronary artery bypass graft surgery
  • Atrioventricular block in first ECG
  • ST elevation myocardial infarction
  • History of renal failure ( exception patients underwent hemodialysis)
  • Need for Target vessel revascularization ( TVR )
  • The coronary artery stenosis will not be suitable for angioplasty

Outcomes

Primary Outcomes

Not specified

Similar Trials